https://orcid.org/0000-0001-6075-489X
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Declaration of interest
B Keenan has grant funding from NIH T32AI007334 and the Conquer Cancer Foundation, American Society of Clinical Oncology, and research support from Partner Therapeutics.
RK Kelley has research support from Agios, Astra Zeneca, Bayer, BMS, Eli Lilly, EMD Serono, Exelixis, Merck, Partner Therapeutics, QED, Novartis, and Taiho (all to institution). She receives consulting/steering committee fees to her institution from Astra Zeneca, BMS, and Agios, and receives advisory/IDMC fees from GNE/Roche, Ipsen, and Gilead. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.